Vascular Ehlers-Danlos Syndrome (VEDS)Symptoms, Doctors, Treatments, Advances & More
Vascular Ehlers-Danlos Syndrome (VEDS) Overview
Learn About Vascular Ehlers-Danlos Syndrome (VEDS)
Heart And Vascular Center At Durham Outpatient Center
Angela Yetman is a Cardiologist and a Pediatric Cardiologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 35 years. Dr. Yetman is rated as an Advanced provider by MediFind in the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Marfan Syndrome, Turner Syndrome, Congenital Contractural Arachnodactyly, and Congenital Heart Disease (CHD).
Xavier Jeunemaitre practices practicing medicine in Paris, France. Mr. Jeunemaitre is rated as an Elite expert by MediFind in the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Vascular Ehlers-Danlos Syndrome (VEDS), Fibromuscular Dysplasia (FMD), Ehlers-Danlos Syndrome (EDS), Pseudohypoaldosteronism Type 1, and Angioplasty.
The Association Of University Physicians
Peter Byers is a Medical Genetics provider practicing medicine in Seattle, Washington. Dr. Byers is rated as an Elite provider by MediFind in the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ehlers-Danlos Syndrome (EDS), Vascular Ehlers-Danlos Syndrome (VEDS), Osteogenesis Imperfecta, and De Barsy Syndrome. Dr. Byers is currently accepting new patients.
Summary: This research study will investigate whether people with vascular Ehlers-Danlos syndrome (vEDS), a rare inherited condition, have problems with the way their body stores and uses fat (adipose tissue). vEDS is caused by changes in a gene called COL3A1, which makes a protein important for the structure of many tissues. While vEDS is best known for making blood vessels fragile, there is some early ev...
Summary: This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.
